Calix (CALX) PT Raised to $73 at Needham & Company
- Stocks decline as interest rate uncertainty, earnings weigh
- ASML slides as Q1 sales fall short but firm still on track for 2025 revenue target
- US dollar weakens as market consolidates gains, but uptrend intact
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
- Stocks have priced in much of the 2024 optimism - Wells Fargo
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- Barnes & Noble Education (BNED) Enters Definitive Agreement with Immersion (IMMR)
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
Calix (CALX) PT Raised to $73 at Barrington Research
October 26, 2021 3:43 PM EDTBarrington Research analyst Christopher Howe raised the price target on Calix (NYSE: CALX) to $73.00 (from $58.00) while maintaining a Outperform rating.
... MoreCalix, Inc. (CALX) Tops Q3 EPS by 6c, Offers Q4 Guidance
October 25, 2021 5:28 PM EDTCalix, Inc. (NYSE: CALX) reported Q3 EPS of $0.35, $0.06 better than the analyst estimate of $0.29. Revenue for the quarter came in at $172.2 million versus the consensus estimate of $167.59 million.
GUIDANCE:
Calix, Inc. sees Q4 2021 EPS of $0.20-$0.25, versus the consensus of... More